1. How does Emily's history of recurrent urinary tract infections and frequent antibiotic use contribute to her increased risk of developing a Candida albicans infection?
2. In what ways might Emily's use of oral contraceptives influence her susceptibility to vulvovaginal candidiasis, and what epidemiological evidence supports this association?
3. Considering Emily's lifestyle and work-related stress, how might these factors indirectly affect her immune system and predispose her to Candida infections?
4. What preventive measures could have been recommended to Emily to reduce her risk of developing a Candida albicans infection following her recent antibiotic treatment?
5. How does Emily's mild asthma and the use of an albuterol inhaler potentially interact with her risk factors for Candida albicans infection, and what implications does this have for her management?